The heterogeneity of fatigue in different stages of Parkinson’s disease
Objective: To identify factors associated with fatigue in different stages of PD. Background: Fatigue is an important contributor to poor quality of life. However, it…P100 latency of pattern reversal visual evoked potential and visual hallucination in Parkinson’s disease
Objective: To investigate whether P100 latency of pattern reversal visual evoked potential (PR-VEP) can predict the development of visual hallucination (VH) in Parkinson's disease (PD).…Clinical and biological predictors of excessive daytime sleepiness in early Parkinson’s disease
Objective: To examine longitudinal change in excessive daytime sleepiness (EDS) and to determine clinical and biological variables that predict new onset EDS in the cohort…Frequency of non-motor symptoms in Iranian patients with Parkinson’s disease
Objective: To evaluate prevalence of nanometer symptoms in patients with Parkinson's disease. Background: While PD (Parkinson's disease) is diagnosed on the basis of motor symptoms,…Movement disorders (Parkinson’s disease) in Uzbekistan: Epidemiologic, clinical and therapeutic aspects
Objective: The aim was to determine the epidemiologic, clinical and therapeutic aspects of patients treated for PD. Methods: This was a prospective and cross-sectional study…Prevalence of Parkinson’s disease in the region of Coquimbo, Chile
Objective: To determine the rate of prevalence of PD in the region of Coquimbo, Chile. Background: Parkinson's disease is a common neurodegenerative disease, second after…Non-contact boxing in Parkinson’s disease
Objective: To narratively review the effectiveness of non-contact boxing and explore its feasibility in individuals with Parkinson's disease (PD). Background: Complementary therapies have shown outcomes…Longitudinal assessment of caregiver strain in Parkinson’s disease
Objective: To examine changes in caregivers and predictors of increased caregiver strain in Parkinson's disease (PD). Background: Caregiver strain can increase with advanced PD. In…Quantifying turning behavior in Parkinson’s disease patients using mobile technology
Objective: To use inertial measurement unit (IMU) data from a mobile device, iPad or iPhone, to quantify PD patients' gait and turning behavior, on and…The role of non-steroidal anti-inflammatory use in symptomatic and asymptomatic LRRK2 G2019S mutation carriers
Objective: The purpose of the current study is to determine if non-steroidal anti-inflammatory drugs (NSAIDs) reduce the risk of Parkinson's disease (PD) among LRRK2 G2019S…
- « Previous Page
- 1
- …
- 310
- 311
- 312
- 313
- 314
- …
- 388
- Next Page »